PAL S. "EVALUATION OF CYSTATIN C AS AN EARLY MARKER OF RENAL IMPAIRMENT IN DIABETIC AND HYPERLIPIDAEMIC PATIENTS." World Research Journal of Medical Science 1.1 (2013):13-17.